Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Coronavirus Infection

Open-data reference.

13 US clinical trials · 3 currently recruiting

Active & Recent Trials

RECRUITING 1,000 participants

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

Columbia University

NCT04367857

RECRUITING Phase 3 240 participants

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

West Virginia University

NCT04376034

RECRUITING 100 participants

Post COVID-19 Biorepository

University of Kansas Medical Center

NCT04885504

COMPLETED NA 831 participants

Community Collaboration to Combat COVID-19 (C-FORWARD)

Johns Hopkins University

NCT04673292

COMPLETED Phase 2 368 participants

University of Utah COVID-19 Hydrochloroquine Trial

University of Utah

NCT04342169

COMPLETED 155 participants

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)

University of Washington

NCT05074719

COMPLETED 129 participants

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

University of Minnesota

NCT04339998

COMPLETED 79 participants

WGS Analysis of COVID-19 Positive Patients

Vanda Pharmaceuticals

NCT04353401

COMPLETED 76 participants

COVID-19 and Lactating Mothers

University of Rochester

NCT04558320

COMPLETED Phase 1 72 participants

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Apellis Pharmaceuticals

NCT04402060

COMPLETED Phase 2 55 participants

COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications

James L. Kirkland, MD, PhD

NCT04771611

COMPLETED 29 participants

Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure

Columbia University

NCT04408222

COMPLETED NA 20 participants

Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

University of Oklahoma

NCT04416919

Phase Distribution

PhaseTrial count
Early Phase 1 1
Phase 2 2
Phase 3 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Coronavirus Infection Trial Landscape

ClinicalTrials.gov lists 13 US studies indexed under Coronavirus Infection, and 3 of those are currently open to recruitment — roughly 23% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Coronavirus Infection shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Coronavirus Infection is led by Columbia University with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Coronavirus Infection?

PlainTrial tracks 13 US clinical trials for Coronavirus Infection, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Coronavirus Infection?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →